​​​​​ The U.S. Food and Drug Administration (FDA) today announced it granted Emergency Use Authorization to Ortho Clinical Diagnostics’ total antibody assay for COVID-19—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack and Calibrators.

Aligned with its mission to improve and save lives with diagnostics, Ortho Clinical Diagnostics today announced it is launching to market its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack.

​​​​​ Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced it has been honored with a bronze Edison Award in the category of Medical/Dental Testing Solutions for its VITROS® XT Solutions,

​​​​​ Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, announced its ORTHO Sera, ID-MTS, a suite of extended antigen in a gel testing format used for blood phenotyping for patients in need of

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its VITROS ®  B•R•A•H•M•S PCT (Procalcitonin) assay to help clinicians

Recognition is latest for Ortho Care™, Ortho’s award-winning customer service and support program Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, has been named a bronze medal winner at the 14th

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the launch and availability of the VITROS XT 3400 Chemistry System, which completes the company’s VITROS XT Solutions, a comprehensive

Recognition follows numerous honors for Ortho’s industry-leading customer service and support Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, was recognized  with a Silver Award for an innovative

Ortho Clinical Diagnostics Enters Into a $375 Million Euro-Denominated Term Loan and Issues $675 Million in Senior Notes to Refinance $1 Billion of its $1.3 Billion 6.625 Percent Senior Notes Due in 2022 Ortho Clinical Diagnostics (“Ortho” or the “Company”), a global leader of in vitro diagnostics

What are the biggest challenges for marketers in 2020? Matthew Dawson, our director of global marketing for transfusion medicine, tells PM360 magazine that it’s better alignment between sales and marketing.  “While salespeople can only be in front of one person at a time, marketing makes